AstraZeneca Revenue Hurt as Demand for COVID-19 Treatments Slumps; Stock Drops
AstraZeneca PLC missed Q4 profit forecasts as its revenue was slowed by falling demand for COVID-19 vaccines and medicines.
( 18
min )